Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 76,330
  • Shares Outstanding, K 35,836
  • Annual Sales, $ 0 K
  • Annual Income, $ -31,800 K
  • 60-Month Beta 1.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.00
Trade HUGE.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.75
  • Most Recent Earnings -0.36 on 06/30/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.880 +10.11%
on 08/20/21
2.420 -14.46%
on 08/25/21
+0.130 (+6.70%)
since 08/16/21
3-Month
1.880 +10.11%
on 08/20/21
2.460 -15.85%
on 06/22/21
-0.170 (-7.59%)
since 06/16/21
52-Week
1.700 +21.76%
on 11/13/20
5.240 -60.50%
on 02/11/21
-1.680 (-44.80%)
since 09/16/20

Most Recent Stories

More News
InvestmentPitch Media Video Discusses FSD Pharma's Definitive Agreement to Acquire 100% of Lucid Psycheceuticals Inc. - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - August 26, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide ("PEA"), or...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
InvestmentPitch Media Video Discusses FSD Pharma's Termination of its CEO, Dr. Raza Bokhari, for Cause - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a specialty, biotech pharmaceutical R&D company, has terminated its CEO, Dr. Raza...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for Cause

FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") announced today that the board of directors had terminated the employment of the Company's Chief Executive Officer, Dr. Raza...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Inc. Appoints a New Independent Director

FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") is pleased to announce the appointment of Mr. Adnan Bashir as an independent member of its Board of Directors (the "Board"),...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Inc. Announces Results of the Annual General and Special Meeting of Shareholders - Nominees of the Concerned Shareholders Elected to the Board of Directors

FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") is pleased to announce the results of its annual general and special meeting of the shareholders held on May 14th, 2021 (the...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Announces Filing of Criminal Complaint Against Former Chief Financial Officer

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") announced today that it has filed a criminal complaint with Toronto Police Services, Financial Crimes Unit, against Mr. Donal Carroll,...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Management and Board Suffers Multiple Court Losses as Shareholder Meeting Approaches

Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - On Monday, May 10, 2021, at the request of Messrs. Anthony Durkacz and Zeeshan Saeed, founding shareholders and members of the group of concerned shareholders...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)
FSD Pharma Announces That ISS Recommends Shareholders Vote for the Company's Nominees to the Board Using Only the BLUE Proxy

FSD Pharma Inc. (the "Company") today announced that Institutional Shareholder Services Inc. ("ISS"), a leading independent international corporate governance analysis and proxy advisory firm, has recommended...

HUGE : 1.6200 (-3.57%)
HUGE.CN : 2.070 (-2.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 2.300
2nd Resistance Point 2.230
1st Resistance Point 2.150
Last Price 2.070
1st Support Level 2.000
2nd Support Level 1.930
3rd Support Level 1.850

See More

52-Week High 5.240
Fibonacci 61.8% 3.888
Fibonacci 50% 3.470
Fibonacci 38.2% 3.052
Last Price 2.070
52-Week Low 1.700

See More

Business Summary

FSD Pharma Inc, through its wholly-owned subsidiary, is focused on Pharmaceutical research and development of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine. The FSD 201 is known to stabilize mast cells of the human body and down-regulate the proinflammatory cytokines to effectuate...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar